Continuous glucose monitoring for newly diagnosed type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study looks at whether using a continuous glucose monitor (a small sensor that checks blood sugar levels around the clock) can help people who were just diagnosed with type 2 diabetes manage their blood sugar better. If you join, you would wear the sensor for a while and get regular feedback, which might help you learn how food and habits affect your sugar levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You were diagnosed with type 2 diabetes within the last 4 weeks
- Your HbA1c (average blood sugar over time) is at least 7.5% but below 11%
- You have a body mass index (BMI) above 25, which means you are above the healthy weight range
- You are not pregnant and do not plan to become pregnant during the study
- You don't have any skin problems at the sensor placement spots
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of tracking blood sugar in people with type 2 diabetes who use insulin. It aims to see if one method helps manage glucose better, which could improve daily control and long-term health.
This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.
This trial tests a new continuous glucose monitor (a small sensor that checks blood sugar levels) to see how well and safely it works in people with type 1 diabetes. You'll wear the sensor for 15 days and attend three clinic visits to check its accuracy against blood samples.
This study checks whether using a continuous glucose monitor (CGM, a sensor that tracks blood sugar) is practical and helpful for people with type 2 diabetes in primary care settings. It focuses on people who may have a harder time getting diabetes support and have higher A1c levels.
This study compares wearing a continuous glucose monitor (CGM) all the time versus only now and then for people with type 2 diabetes who do not use insulin. It aims to see which way helps manage blood sugar better.
This study looks at using a continuous glucose monitor (a small sensor that tracks blood sugar all day) in people with type 2 diabetes who are not taking insulin. It aims to see if using the monitor helps improve blood sugar control.
Hear when a new Diabetes Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.